SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
Under the Securities Exchange Act of 1934
(Amendment No. ______)
MED GEN, INC.
-----------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 Par Value Per Share
-----------------------------------------------------------------------
(Title of Class of Securities)
58401X-407
-----------------------------------------------------------------------
(CUSIP Number)
Paul Mitchell, President
Med Gen, Inc.
7040 W. Palmetto Park Road, Suite 4,Box 716
Boca Raton, Florida 33433 (561) 750-1100
-----------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 12, 2009
-----------------------------------------------------------------------
Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D,
and is filing this Schedule because of Rule 13d-1(b)(3) or (4), check
the following box: [ ].
Note. Six copies of this statement, including all exhibits, should
be filed with the Commission. See Rule 13d-1(a) for other parties to
whom copies are to be sent.
(Continued on following pages)
(Page 1 of 4 Pages)
13D
CUSIP NO.58401X-20-9 Page 2 of 4 Pages
1. Names of Reporting Persons. I.R.S. Identification Nos. of
above Persons
Paul Kravitz
2. Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
3. SEC Use Only
4. Source of Funds
SC
5. Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e) [ ]
6. Citizenship or Place of Organization
Paul Kravitz - United States
Number of Shares Beneficially Owned by Each Reporting Person With:
7. Sole Voting Power
550,050,393
8. Shared Voting Power
-0-
9. Sole Dispositive Power
550,050,393
10. Shared Dispositive Power
-0-
11. Aggregate Amount Beneficially Owned by Each Reporting Person
550,050,393
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares [ ]
13D
CUSIP NO. 58401X-407 Page 3 of 4 Pages
13. Percent of Class Represented by Amount of Row (11): 26.78%
14. Type of Reporting Person: IN
ITEM 1. SECURITY AND ISSUER
The class of equity securities to which this Schedule 13D relates
is the common stock, $.001 par value, of Med Gen, Inc., a Nevada
corporation ("Med Gen".) The address of the principal executive
office of Med Gen is 7040 W. Palmetto Park Road, Suite 4 Box 716, Boca
Raton, Florida 33433; telephone (561) 750-1100.
ITEM 2. IDENTITY AND BACKGROUND.
(a) This Schedule 13D is filed by Paul Kravitz on behalf of himself.
(b) Paul Kravitz has his principal business and office address at
7040 W. Palmetto Park Road, Suite 4 Box 716 Boca Raton, Florida 33433.
(c) Paul Kravitz's principal occupation is CEO of Med Gen, Inc. He
is employed by Med Gen, Inc.
(d) During the last five years, Paul Kravitz has not been convicted
in a criminal proceeding (excluding traffic violations or similar
misdemeanors.)
(e) During the last five years, Paul Kravitz has not been a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction where, as a result of such proceeding, a judgment, decree or
final order was entered enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or
finding any violation with respect to such laws.
(f) Paul Kravitz is a citizen of the United States.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
See Item 4., Purpose of Transaction, below.
13D
CUSIP NO. 58401X-407 Page 4 of 4 Pages
ITEM 4. PURPOSE OF TRANSACTION.
The Board of Directors issued 400,000,000 common shares to Mr. Kravitz
Pursuant to the terms of the Convertible Preferred shares.
ITEM 5. INTEREST IN SECURITIES OF MED GEN.
Paul Kravitz is the direct owner of 550,050,393 shares, or 26.78% of
Med Gen's issued and outstanding common stock. Paul Kravitz has
disposed of 50,000,000 shares of common stock of Med Gen within the past 60
days and filed Form 4 late as required under the Securities Act.The late
filing was required because of his illness , surgery and medications.
In the event of a default on the convertible debenture notes ,NIR Group
has the right to receive the proceeds of the sale of the shares owned
by Paul Kravitz. He has pledged these shares as collateral for all of
the 8% Convertible debentures.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF MED GEN
In the event of a default on the convertible debenture notes ,NIR Group
has the right to receive the proceeds of the sale of the shares owned
by Paul Kravitz. He has pledged these shares as collateral for all of
the 8% Convertible debentures.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.
Med Gen, Inc.
By:/s/Paul Kravitz
---------------------------
Paul Kravitz,
Title: President
/s/Paul Kravitz
---------------------------
Paul Kravitz, Individually
MedGen (CE) (USOTC:MDIN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
MedGen (CE) (USOTC:MDIN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
